LYNX-2: A Pivotal Phase 3 Trial of Phentolamine Ophthalmic Solution in Post-Keratorefractive Surgery Subjects with Decreased Mesopic Visual Acuity
LYNX-1 Phase 3 Trial of the Safety and Efficacy of Phentolamine Ophthalmic Solution for the Treatment of Reduced Mesopic Low Contrast Vision: A Subset Analysis of Keratorefractive Subjects
April 2025: Randomized, Controlled, Phase 3 Studies of Phentolamine Solution in Keratorefractive Patients with Low Mesopic Vision and Photic Complaints
A Randomized Phase 2 Clinical Trial of Phentolamine Mesylate Eye Drops in Patients with Severe Night Vision Disturbances
